Crossref indexed
Cancer Chemotherapy and Pharmacology
Published by Springer-Verlag.
ISSN 0344-5704 / 1432-0843
Submit to this journal
01
Aims & scope
Cancer Chemotherapy and Pharmacology publishes peer-reviewed research. Manuscripts pass a technical check and a scope check by the handling editor before going to independent reviewers.
02
Recently published
Impact of adverse events on survival outcomes in patients treated with CDK4/6 inhibitors for advanced breast cancer
DOI 10.1007/s00280-025-04836-y Martina Catalano, Gestiana Cekrezi, Irene De Gennaro Aquino, Delia Ravizza, Alexandra Paulet, Kristian Shtembari, Claudia De Angelis, Roberto Petrioli, Daniele Generali, Giandomenico Roviello · 2025
Presence of drug-drug interactions between esomeprazole and an ALK tyrosine kinase inhibitor (Dirozalkib)
DOI 10.1007/s00280-025-04837-x Lin Fang, Xin Jiang, Kexiu Song, Ping Shi, Li Wang, Lingmei Xu, Xianghui Duan, Fei Liu, Feifei Sun, Rongxin Ban, Yaping Ma, Chenjing Wang, Yu Cao · 2025
Association of DPYD rs4294451, plasma uracil concentration, and sex with 5-fluorouracil exposure in patients with gastrointestinal cancer
DOI 10.1007/s00280-025-04851-z Gabriel A. Brooks, Dylan B. Ness, Kathryn C. Hourdequin, Gregory H. Ripple, Manik Amin, Sierra Lord-Halvorson, Wahab A. Khan, Sophie J. Deharvengt, Vincent Busque, Konstantin H. Dragnev, Wenyan Zhao, Tor D. Tosteson, Lionel D. Lewis · 2025
6-gingerol alleviates chemotherapy-induced nausea and vomiting by inhibiting ferroptosis via the regulation of iron homeostasis
DOI 10.1007/s00280-025-04850-0 Wan Liang, Lei Feng, Siyu Han, Chenglu Yang, Binbin Ye, Ziyao Mo, Ke Nie · 2025
Mechanisms of resistance to antibody-drug conjugates in cancer: molecular barriers and pharmacological solutions
DOI 10.1007/s00280-025-04848-8 Lina Eltaib, Muhammad Afzal, Chandana Maji, H. Malathi, Kavita Goyal, Haider Ali, Gaurav Gupta, Md Sadique Hussain · 2025
Potential clinical relevance of rare dihydropyrimidine dehydrogenase genetic variants identified using whole-exome NextGen sequencing in cancer patients with severe fluoropyrimidine toxicity
DOI 10.1007/s00280-025-04839-9 Elizabeth Cui, Samantha Medwid, Ute I. Schwarz, Richard B. Kim · 2025
Lack of effects of S-equol-containing supplement on the pharmacokinetics of oral hormone therapy drugs for breast cancer
DOI 10.1007/s00280-025-04852-y Takehiko Sambe, Chiyo K. Imamura, Noriko Hida, Taigi Yamazaki, Takuya Mizukami, Kakei Ryu, Koya Fukunaga, Taisei Mushiroda, Haruna Miyakawa, Shigeto Uchiyama, Naoki Uchida, Shinichi Kobayashi · 2025
Benefit of plasma cystatin C for carboplatin individual dosing in a patient with spinal amyotrophy
DOI 10.1007/s00280-025-04847-9 Matthieu Gracia, Sabrina Marsili, Julien Vintejoux, Laurence Gladieff, Etienne Chatelut, Fabienne Thomas · 2025
Pharmacokinetic comparison of cisplatin administration via HIPEC and intravenous infusion in a porcine model
DOI 10.1007/s00280-025-04843-z Christina Harlev, Elisabeth Krogsgaard Petersen, Mats Bue, Lone Kjeld Petersen, Johanne Gade Lilleøre, Anne Vibeke Schmedes, Bo Martin Bibby, Maiken Stilling · 2025
Selection of isatuximab dosing regimen in pediatric patients with leukemia using population pharmacokinetics
DOI 10.1007/s00280-025-04832-2 Claire Brillac, Dorothée Sémiond, Corina Oprea, André Baruchel, C. Michel Zwaan, Laurent Nguyen · 2025
Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancer
DOI 10.1007/s00280-025-04840-2 Stuthi Perimbeti, Anmbreen Jamroze, Dharmesh Gopalakrishnan, Rohit Jain, Changchuan Jiang, Julianne L. Holleran, Robert A. Parise, Robert Bies, David Quinn, Kristopher Attwood, Xiaozhuo Liu, Kelly Green, Jason S. Kirk, Jan H. Beumer, Dean G. Tang, Gurkamal Chatta · 2025
A novel Ondansetron extended release injectable suspension (OERIS): evaluation of Safety, tolerability and pharmacokinetics in a phase I trial
DOI 10.1007/s00280-025-04820-6 Veerendra Kumar Panuganti, Chandrasekhar Varma Alluri, Venkata Ramalingayya Grandhi, Javeed Mohammad, Sanyasirao K. S. S. V. V., Mamatha Reddy Dundigalla, Pavan Kumar Madala · 2025
Journal metrics
Total DOIs9,820
Current DOIs345
Backfile DOIs9,475
Published here0
Publish with us
Five steps, about 15 minutes. You can save and come back at any point.
Submit manuscript